Literature DB >> 29179622

Traumatic Brain Injury Impairs Myogenic Constriction of Cerebral Arteries: Role of Mitochondria-Derived H2O2 and TRPV4-Dependent Activation of BKca Channels.

Nikolett Szarka1,2,3, Mallikarjuna R Pabbidi4, Krisztina Amrein1,2, Endre Czeiter1,2,5, Gergely Berta6, Krisztina Pohoczky7,8, Zsuzsanna Helyes7,8, Zoltan Ungvari9, Akos Koller1,10,11, Andras Buki1,2, Peter Toth1,2,3,5,9.   

Abstract

Traumatic brain injury (TBI) impairs autoregulation of cerebral blood flow, which contributes to the development of secondary brain injury, increasing mortality of patients. Impairment of pressure-induced myogenic constriction of cerebral arteries plays a critical role in autoregulatory dysfunction; however, the underlying cellular and molecular mechanisms are not well understood. To determine the role of mitochondria-derived H2O2 and large-conductance calcium-activated potassium channels (BKCa) in myogenic autoregulatory dysfunction, middle cerebral arteries (MCAs) were isolated from rats with severe weight drop-impact acceleration brain injury. We found that 24 h post-TBI MCAs exhibited impaired myogenic constriction, which was restored by treatment with a mitochondria-targeted antioxidant (mitoTEMPO), by scavenging of H2O2 (polyethylene glycol [PEG]-catalase) and by blocking both BKCa channels (paxilline) and transient receptor potential cation channel subfamily V member 4 (TRPV4) channels (HC 067047). Further, exogenous administration of H2O2 elicited significant dilation of MCAs, which was inhibited by blocking either BKCa or TRPV4 channels. Vasodilation induced by the TRPV4 agonist GSK1016790A was inhibited by paxilline. In cultured vascular smooth muscle cells H2O2 activated BKCa currents, which were inhibited by blockade of TRPV4 channels. Collectively, our results suggest that after TBI, excessive mitochondria-derived H2O2 activates BKCa channels via a TRPV4-dependent pathway in the vascular smooth muscle cells, which impairs pressure-induced constriction of cerebral arteries. Future studies should elucidate the therapeutic potential of pharmacological targeting of this pathway in TBI, to restore autoregulatory function in order to prevent secondary brain damage and decrease mortality.

Entities:  

Keywords:  autoregulation; intracranial hypertension; oxidative stress; secondary injury

Year:  2018        PMID: 29179622      PMCID: PMC5865628          DOI: 10.1089/neu.2017.5056

Source DB:  PubMed          Journal:  J Neurotrauma        ISSN: 0897-7151            Impact factor:   5.269


  20 in total

1.  mtROS-Induced TRPV4 Activation in Traumatic Brain Injury.

Authors:  Karthik Suresh
Journal:  J Neurotrauma       Date:  2018-07-05       Impact factor: 5.269

2.  Hypertension Exacerbates Cerebrovascular Oxidative Stress Induced by Mild Traumatic Brain Injury: Protective Effects of the Mitochondria-Targeted Antioxidative Peptide SS-31.

Authors:  Andras Czigler; Luca Toth; Nikolett Szarka; Gergely Berta; Kriszitina Amrein; Endre Czeiter; Dominika Lendvai-Emmert; Kornelia Bodo; Stefano Tarantini; Akos Koller; Zoltan Ungvari; Andras Buki; Peter Toth
Journal:  J Neurotrauma       Date:  2019-08-01       Impact factor: 5.269

3.  Reactive oxygen species induced Ca2+ influx via TRPV4 and microvascular endothelial dysfunction in the SU5416/hypoxia model of pulmonary arterial hypertension.

Authors:  Karthik Suresh; Laura Servinsky; Haiyang Jiang; Zahna Bigham; Xin Yun; Corrine Kliment; John Huetsch; Mahendra Damarla; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2018-02-01       Impact factor: 5.464

4.  Kaempferol Treatment after Traumatic Brain Injury during Early Development Mitigates Brain Parenchymal Microstructure and Neural Functional Connectivity Deterioration at Adolescence.

Authors:  Maxime Parent; Jyothsna Chitturi; Vijayalakshmi Santhakumar; Fahmeed Hyder; Basavaraju G Sanganahalli; Sridhar S Kannurpatti
Journal:  J Neurotrauma       Date:  2020-02-06       Impact factor: 5.269

5.  Regulation of mitochondrial fragmentation in microvascular endothelial cells isolated from the SU5416/hypoxia model of pulmonary arterial hypertension.

Authors:  Karthik Suresh; Laura Servinsky; Haiyang Jiang; Zahna Bigham; Joel Zaldumbide; John C Huetsch; Corrine Kliment; Michelle G Acoba; Brian J Kirsch; Steven M Claypool; Anne Le; Mahendra Damarla; Larissa A Shimoda
Journal:  Am J Physiol Lung Cell Mol Physiol       Date:  2019-08-28       Impact factor: 5.464

6.  Luseogliflozin, a sodium-glucose cotransporter-2 inhibitor, reverses cerebrovascular dysfunction and cognitive impairments in 18-mo-old diabetic animals.

Authors:  Shaoxun Wang; Feng Jiao; Jane J Border; Xing Fang; Reece F Crumpler; Yedan Liu; Huawei Zhang; Joshua Jefferson; Ya Guo; Parker S Elliott; Kirby N Thomas; Luke B Strong; Austin H Urvina; Baoying Zheng; Arjun Rijal; Stanley V Smith; Hongwei Yu; Richard J Roman; Fan Fan
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-12-24       Impact factor: 4.733

Review 7.  Aging-Induced Impairment of Vascular Function: Mitochondrial Redox Contributions and Physiological/Clinical Implications.

Authors:  Evan Paul Tracy; William Hughes; Jason E Beare; Gabrielle Rowe; Andreas Beyer; Amanda Jo LeBlanc
Journal:  Antioxid Redox Signal       Date:  2021-09-17       Impact factor: 7.468

8.  Relationship of Cerebral Blood Flow to Cognitive Function and Recovery in Early Chronic Traumatic Brain Injury.

Authors:  Jeffrey B Ware; Sudipto Dolui; Jeffrey Duda; Naomi Gaggi; Robin Choi; John Detre; John Whyte; Ramon Diaz-Arrastia; Junghoon J Kim
Journal:  J Neurotrauma       Date:  2020-06-11       Impact factor: 4.869

9.  Induction of oxidative stress and apoptosis in the injured brain: potential relevance to brain regeneration in zebrafish.

Authors:  Surendra Kumar Anand; Manas Ranjan Sahu; Amal Chandra Mondal
Journal:  Mol Biol Rep       Date:  2021-06-24       Impact factor: 2.316

Review 10.  Traumatic Brain Injury and Alzheimer's Disease: The Cerebrovascular Link.

Authors:  Jaime Ramos-Cejudo; Thomas Wisniewski; Charles Marmar; Henrik Zetterberg; Kaj Blennow; Mony J de Leon; Silvia Fossati
Journal:  EBioMedicine       Date:  2018-01-31       Impact factor: 8.143

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.